Carl Zeiss Meditec announces 510k clearance from the FDA for ZEISS CLINIC 360 (€31.96, +0.74)
Carl Zeiss Meditec downgraded to reduce from hold at Kepler Cheuvreux (€29.82, 0.00)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Carl Zeiss Meditec downgraded to sell from neutral at UBS (€30.00, 0.00)
Transcript Intelligence: Carl Zeiss Meditec Q3 Earnings Guidance
Transcript Intelligence: Carl Zeiss Meditec Q3 Earnings Themes
Carl Zeiss Meditec downgraded to sell from hold at mwb research (timing uncertain) (€28.88, -1.40)
Powered by FactSet Research Systems Inc.